Comparative Pharmacology
Head-to-head clinical analysis: OTOBIONE versus PEDIOTIC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OTOBIONE versus PEDIOTIC.
OTOBIONE vs PEDIOTIC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
OTOBIONE is a combination product containing ciprofloxacin (a fluoroquinolone antibiotic) and fluocinolone acetonide (a corticosteroid). Ciprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, leading to bacterial cell death. Fluocinolone acetonide suppresses inflammation by binding to glucocorticoid receptors, inhibiting phospholipase A2, and reducing prostaglandin and leukotriene synthesis.
PEDIOTIC contains hydrocortisone, neomycin, and polymyxin B. Neomycin and polymyxin B are antibiotics that inhibit bacterial protein synthesis and disrupt bacterial cell membrane integrity, respectively. Hydrocortisone is a corticosteroid that suppresses inflammation by inhibiting phospholipase A2, reducing prostaglandin and leukotriene synthesis.
1-2 drops in affected ear(s) twice daily; otic administration only.
Instill 4 drops into the affected ear(s) twice daily for 7-10 days.
None Documented
None Documented
2.5 hours (prolonged to 12-24 hours in renal impairment, CrCl <30 mL/min)
Not established for topical otic use; systemic absorption is minimal. If absorbed, terminal half-life of dexamethasone is approximately 3-4 hours.
Renal: 90% unchanged; biliary: <5% as metabolites; fecal: <2%
Renal elimination of absorbed drug (primarily unchanged) accounts for <10% of topically applied dose; fecal/biliary routes negligible.
Category C
Category C
Otic Antibiotic/Corticosteroid
Otic Antibiotic/Corticosteroid Combination